Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. (Q53160358)
Jump to navigation
Jump to search
scientific article published on 28 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. |
scientific article published on 28 June 2012 |
Statements
Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. (English)
1 reference
Shu-Wen Jao
1 reference
Su-Feng Chen
1 reference
Yaoh-Shiang Lin
1 reference
Yun-Ching Chang
1 reference
Tsai-Yu Lee
1 reference
Chang-Chieh Wu
1 reference
Jong-Shiaw Jin
1 reference
Shin Nieh
1 reference
28 June 2012
1 reference
19
1 reference
11
1 reference
3432-3440
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference